In a prospective naturalistic study, Wilberg and her colleagues (2003) evaluated the effectiveness of outpatient psychodynamic group therapy in a population of poorly functioning patients with personality disorders (PD) following their participation in an intensive time-limited day treatment program (which largely consisted of psychodynamic and cognitive behavioral therapy groups). The outpatient groups met for 1.5 hours each week and were led by a co-therapy team formally trained in group analysis according to Foulkesian principles (Foulkes & Anthony, 1957) . The investigators gave no detailed description of the therapeutic approach, however, and there was no indication of a specific treatment manual or method of assuring adherence to the treatment model. The therapy groups were comprised of patients with various PDs as well as a few with Axis I disorders, with assessments based on structured clinical interviews and clinical observations made during day treatment. The effectiveness of the outpatient groups was assessed using a variety of outcome measures, such as the Global Assessment of Functioning Scale (GAF), the Global Severity Index (GSI) of the Symptom Check List, and a 47-item version of the Inventory of Interpersonal Problems (IIP-C) called the Circumplex of Interpersonal Problems (CIP). Patients were given these measures at admission to and discharge from day treatment and at termination of outpatient group therapy. Although 312 patients entered the outpatient therapy groups, a number either terminated prematurely or had incomplete datasets. The final study sample consisted of 187 patients, of whom 73% were female and 86% had an Axis II diagnosis, including avoidant (48%), borderline (28%), dependent (17%), unspecified (17%), paranoid (10%), and obsessive-compulsive (9%) PD. The remaining 14% without a PD were included as a comparison group. Study patients participated in a mean of 20.1 weeks of day treatment and 24.4 months of outpatient group therapy.
Based on a variety of statistical procedures, the results indicated that there were significant improvements in GAF, GSI, and CIP scores from the beginning of day treatment to the end of outpatient group therapy, and from the beginning to the end of outpa-tient group therapy alone. The effect sizes were in the moderate to large range. These overall improvements were found for both PD and non-PD patients, although comparisons revealed some significant differences in mean scores and in effect sizes that favored the non-PD patients, especially in the outpatient group therapy phase. In addition, the authors found a significant relationship between PD criteria and outcome: the greater the number of PD criteria the more negative the outcomes on GAF, GSI, and CIP scores. Based on previous clinical experience and research (Piper, 1994) , a number of potential predictive and confounding variables were also examined; of note, length of outpatient group therapy, medication usage, or receiving additional individual therapy sessions were not related to outcome.
Overall, the authors concluded that non-PD patients continued to improve in long-term outpatient psychodynamic group therapy but that improvements were more modest for PD patients. In discussing this conclusion, the authors cited two other studies (Bateman & Fonagy, 2001; Chiesa & Fonagy, 2002) where PD patients showed continued improvements in more intensive programs that included twice-weekly group analytic therapy and additional support. They speculated that the dosage of group therapy in the current study may have been insufficient for those with a personality disorder.
The second study by Lorentzen and Hoglend (2004) is actually a follow-up of a previous report by Lorentzen, Bogwald, and Hoglend (2002) on a prospective observational study of 69 outpatients who received long-term psychodynamic group therapy in the context of a psychiatric private practice. The study sample included 54% women, the majority being professional and middle-class. Sixty-seven had a DSM-III-R Axis I diagnosis (mostly affective or anxiety disorders), and 47 had an Axis II diagnosis (two Cluster A, 14 Cluster B, 17 Cluster C, and 14 mixed). As in the study by Wilberg et al., the outpatient therapy groups used in this study met weekly for 1.5 hours and followed a Foulksian group analytical approach, technically described as the psychoanalytic exploring of intrapsychic and interpersonal events; the de-empha-sizing of the role of the therapist; the encouraging of activity by the whole group; and the intervening at the group, subgroup, and individual levels. All three of the studied treatment groups were led by the same experienced male therapist, and one was co-led by an experienced female therapist. Both leaders had completed a 5-year training course in group analysis; the study, however, did not employ a treatment manual or a means for assessing therapy adherence. Outcome measures used in this study were similar to those used by Wilberg et al. and included the GAF, GSI, and IIP-C; comparable scores in the two studies suggested that the Lorentzen et al. patients were higher functioning and less disturbed than the Wilberg et al. patients.
The original report of this study (Lorentzen et al., 2002) evaluated treatment outcome. Results had suggested that large effect sizes and statistically significant positive changes occurred during the 32.5 months of outpatient Foulksian group analysis in terms of psychosocial functioning, symptom reduction, and interpersonal problems. Some of these changes continued during the one-year, post-group follow-up period, with 61% to 86% of the patients showing recovery or significant improvement at the end of follow-up. Only two patients dropped out of group therapy, likely due to patients' agreements at the start of treatment to remain in treatment for at least 6 months. Unfortunately, since the study lacked a control group and a specific treatment manual and adherence measure, any link between the treatment approach and the generally positive outcome is weakened.
The aim of the current report was to identify predictors of outcome in these long-term psychodynamic (Foulksian) groups. Based on the work of Piper (1994) and others, a number of potential predictive variables were selected from seven major domains: demographics, diagnosis, initial severity of disturbance, chronicity, personality, expectancy, and therapeutic process. Five outcome variables (scores on the GAF, GSI, and IIP-C; ratings of global outcome and chief complaints) were regressed on these variables. As expected, both treatment duration and the presence of less initial disturbance were significantly associated with better clinical status in four of the five outcome measures. However, many of the hypothesized associations based on findings from studies of short-term group therapy were not confirmed, suggesting that the specific predictors of outcome for short-term and long-term treatments are different. Notably, the presence or absence of a personality disorder (PD) did not have significant predictive power. In discussing this finding, the authors speculated that their study may not have had enough statistical power to find associations between outcome and the presence of Axis II diagnoses. However, Lorentzen & Hoglend also pointed out that their findings indicated that patients with a PD diagnosis did about the same in their groups as patients without a PD, contrary to the common belief that the presence of a personality disorder is associated with a poorer outcome.
Overall, the two studies reported above suggest that long-term psychodynamic group therapy may be effective for patients with personality disorders, although perhaps less effective than for patients without an Axis II condition. However, since neither study employed a control group or a manualized treatment approach that could indicate that psychodynamic principles were indeed being followed, the validity of this conclusion is open to question. Of course, ethical considerations may limit the feasibility of conducting any rigorous study of long-term psychodynamic group therapy using control groups and randomized assignments to treatment conditions. Also, the funding of such studies may be limited, given the preference by funding agencies for short-term, behaviorally oriented treatment models that utilize specific trainable techniques and have limited quantifiable treatment goals. Nevertheless, the two studies reported here are a promising start; we can hope in the future for better controlled studies that can more rigorously test the effectiveness of long-term psychodynamic group therapy for Axis II patients.
